Barrett J, Shekarabi A, Inan S
Pharmacol Rev. 2023; 75(6):1062-1118.
PMID: 37321860
PMC: 10595024.
DOI: 10.1124/pharmrev.121.000506.
Moerke M, Negus S, Banks M
Drug Alcohol Depend. 2022; 231:109255.
PMID: 34998256
PMC: 8810604.
DOI: 10.1016/j.drugalcdep.2021.109255.
Domi A, Lunerti V, Petrella M, Domi E, Borruto A, Ubaldi M
Br J Pharmacol. 2021; 179(11):2647-2658.
PMID: 34854073
PMC: 9081114.
DOI: 10.1111/bph.15762.
Meyer M, Doshi A, Yasuda D, Zaveri N
AAPS J. 2021; 23(3):68.
PMID: 33974173
DOI: 10.1208/s12248-021-00589-7.
Gastelum C, Perez L, Hernandez J, Le N, Vahrson I, Sayers S
Int J Mol Sci. 2021; 22(5).
PMID: 33800452
PMC: 7962960.
DOI: 10.3390/ijms22052728.
Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.
Burns J, Kroll D, Feldman D, Kure Liu C, Manza P, Wiers C
Front Psychiatry. 2019; 10:626.
PMID: 31620026
PMC: 6759955.
DOI: 10.3389/fpsyt.2019.00626.
NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice.
Brunori G, Weger M, Schoch J, Targowska-Duda K, Barnes M, Borruto A
Alcohol Clin Exp Res. 2019; 43(10):2167-2178.
PMID: 31386211
PMC: 6779486.
DOI: 10.1111/acer.14165.
Targeting opioid dysregulation in depression for the development of novel therapeutics.
Browne C, Lucki I
Pharmacol Ther. 2019; 201:51-76.
PMID: 31051197
PMC: 6859062.
DOI: 10.1016/j.pharmthera.2019.04.009.
The Nociceptin Receptor (NOP) Agonist AT-312 Blocks Acquisition of Morphine- and Cocaine-Induced Conditioned Place Preference in Mice.
Zaveri N, Marquez P, Meyer M, Hamid A, Lutfy K
Front Psychiatry. 2018; 9:638.
PMID: 30555362
PMC: 6281746.
DOI: 10.3389/fpsyt.2018.00638.
A systematic review of the role of the nociceptin receptor system in stress, cognition, and reward: relevance to schizophrenia.
Khan M, Boileau I, Kolla N, Mizrahi R
Transl Psychiatry. 2018; 8(1):38.
PMID: 29391391
PMC: 5804030.
DOI: 10.1038/s41398-017-0080-8.
A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice.
Zaveri N, Marquez P, Meyer M, Polgar W, Hamid A, Lutfy K
Alcohol Clin Exp Res. 2017; 42(2):461-471.
PMID: 29215139
PMC: 5785446.
DOI: 10.1111/acer.13575.
Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.
Zaveri N
J Med Chem. 2016; 59(15):7011-28.
PMID: 26878436
PMC: 5001850.
DOI: 10.1021/acs.jmedchem.5b01499.
The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.
Lutfy K, Zaveri N
Prog Mol Biol Transl Sci. 2016; 137:149-81.
PMID: 26810001
PMC: 5555398.
DOI: 10.1016/bs.pmbts.2015.10.003.
Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats.
Sukhtankar D, Lagorio C, Ko M
Eur J Pharmacol. 2014; 745:182-9.
PMID: 25446568
PMC: 4259829.
DOI: 10.1016/j.ejphar.2014.10.029.
Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I.
Zaveri N, Jiang F, Olsen C, Polgar W, Toll L
Bioorg Med Chem Lett. 2013; 23(11):3308-13.
PMID: 23623415
PMC: 3651809.
DOI: 10.1016/j.bmcl.2013.03.101.
The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice.
Marquez P, Hamid A, Lutfy K
Eur J Pharmacol. 2013; 707(1-3):41-5.
PMID: 23524092
PMC: 3652801.
DOI: 10.1016/j.ejphar.2013.03.021.
Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity.
Vazquez-DeRose J, Stauber G, Khroyan T, Xie X, Zaveri N, Toll L
Eur J Pharmacol. 2012; 699(1-3):200-6.
PMID: 23219985
PMC: 3570659.
DOI: 10.1016/j.ejphar.2012.11.050.
∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells.
Cannarsa R, Carretta D, Lattanzio F, Candeletti S, Romualdi P
J Mol Neurosci. 2011; 46(2):285-92.
PMID: 21603976
DOI: 10.1007/s12031-011-9552-0.
The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
Zaveri N
Curr Top Med Chem. 2010; 11(9):1151-6.
PMID: 21050175
PMC: 3899399.
DOI: 10.2174/156802611795371341.
Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice.
Bebawy D, Marquez P, Samboul S, Parikh D, Hamid A, Lutfy K
Biol Psychiatry. 2010; 68(3):223-30.
PMID: 20359694
PMC: 2896563.
DOI: 10.1016/j.biopsych.2010.02.010.
